140 related articles for article (PubMed ID: 23250619)
1. Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens.
Ichihara K; Masumori N; Kitamura H; Hasegawa T; Tsukamoto T
Int J Clin Oncol; 2014 Feb; 19(1):152-6. PubMed ID: 23250619
[TBL] [Abstract][Full Text] [Related]
2. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
3. Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy.
Ayyathurai R; Gomez P; Luongo T; Soloway MS; Manoharan M
BJU Int; 2007 Nov; 100(5):1021-5. PubMed ID: 17784885
[TBL] [Abstract][Full Text] [Related]
4. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
[TBL] [Abstract][Full Text] [Related]
6. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
Huguet J
Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
[TBL] [Abstract][Full Text] [Related]
7. [Can the prostatic capsule be preserved during cystectomy for bladder tumors: a study of urethral and prostatic involvement in the cystectomy specimens].
Plante P; Lesourd A; Blanchet P; Castagnola C; Coloby P; Daffer N; Davin JL; Desgrandchamps F; Irani J; Marechal JM; Mottet N; Pariente JL
Prog Urol; 1998 Feb; 8(1):47-50. PubMed ID: 9533151
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
Barocas DA; Patel SG; Chang SS; Clark PE; Smith JA; Cookson MS
BJU Int; 2009 Oct; 104(8):1091-7. PubMed ID: 19389006
[TBL] [Abstract][Full Text] [Related]
9. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer?
Barbisan F; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
BJU Int; 2009 Apr; 103(8):1058-63. PubMed ID: 19076141
[TBL] [Abstract][Full Text] [Related]
10. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
Bruins HM; Djaladat H; Ahmadi H; Sherrod A; Cai J; Miranda G; Skinner EC; Daneshmand S
J Urol; 2013 Nov; 190(5):1704-9. PubMed ID: 23707451
[TBL] [Abstract][Full Text] [Related]
11. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
12. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
[TBL] [Abstract][Full Text] [Related]
13. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
Liedberg F; Chebil G; Månsson W
Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
[TBL] [Abstract][Full Text] [Related]
14. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases.
Njinou Ngninkeu B; Lorge F; Moulin P; Jamart J; Van Cangh PJ
J Urol; 2003 Jan; 169(1):149-52. PubMed ID: 12478124
[TBL] [Abstract][Full Text] [Related]
15. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer.
Brant A; Daniels M; Chappidi MR; Joice GA; Sopko NA; Matoso A; Bivalacqua TJ; Kates M
World J Urol; 2019 Dec; 37(12):2683-2689. PubMed ID: 30850856
[TBL] [Abstract][Full Text] [Related]
17. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
[TBL] [Abstract][Full Text] [Related]
18. Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience.
Balcı U; Dogantekin E; Özer K; Görgel SN; Girgin C; Dinçel Ç
Int J Surg; 2015 Jan; 13():148-151. PubMed ID: 25498497
[TBL] [Abstract][Full Text] [Related]
19. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
Frazier HA; Robertson JE; Dodge RK; Paulson DF
Cancer; 1993 Jun; 71(12):3993-4001. PubMed ID: 8508365
[TBL] [Abstract][Full Text] [Related]
20. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
